SEC Form 4 · accession 0000875320-26-000253
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ourania Tatsis
Officer — EVP, Chief Reg. & Quality Off.
Period of report
Jul 21, 2026
Accepted (ET)
Jul 23, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 21, 2026 | A | 8,251 | $0.00 | A | 53,572 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock unit award that vests on 03/31/2030.